Literature DB >> 12601236

Transient cerebellar eye closure and mutism after cerebellar tumor surgery: long-term clinical follow-up of neurologic and behavioral disturbances in a 14-year-old girl.

Coriene E Catsman-Berrevoets1, Hugo R Van Dongen, Femke K Aarsen, Philippe F Paquier.   

Abstract

Transient cerebellar eye closure (TCES) is a complication of cerebellar tumor surgery in children and is almost exclusively observed in the context of the syndrome of mutism and subsequent dysarthria. As knowledge about the course of transient cerebellar eye closure is absent, we describe in detail the clinical picture in a 14-year-old girl. The process of improvement of TCES is characterized by four distinct phases, can last more than 1 month and may be associated with severe persistent cerebellar dysfunction. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12601236     DOI: 10.1159/000068816

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  4 in total

Review 1.  Cause and outcome of cerebellar mutism: evidence from a systematic review.

Authors:  Rosa Reed-Berendt; Bob Phillips; Susan Picton; Paul Chumas; Daniel Warren; John H Livingston; Ellen Hughes; Matthew C H J Morrall
Journal:  Childs Nerv Syst       Date:  2014-01-23       Impact factor: 1.475

2.  Neurobehavioral alterations in an adolescent following posterior fossa tumor resection.

Authors:  Hanne Baillieux; Hyo Jung De Smet; Geoffrey Lesage; Philippe Paquier; Peter P De Deyn; Peter Mariën
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

Review 3.  Cerebellar mutism: review of the literature.

Authors:  Thora Gudrunardottir; Astrid Sehested; Marianne Juhler; Kjeld Schmiegelow
Journal:  Childs Nerv Syst       Date:  2011-03       Impact factor: 1.475

4.  Transient cerebellar eye closure after posterior fossa surgery in a 5-year-old child.

Authors:  Munir J Nasser
Journal:  Childs Nerv Syst       Date:  2009-02-19       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.